Mangalam Drugs Shareholders Approve Appointment of Independent Director Prabhakar Raghunath Zavar
Mangalam Drugs & Organics Ltd 路 Change in Management 路 02 Nov 2026, 9:40 pm
Mangalam Drugs Shareholders Approve Appointment of Independent Director Prabhakar Raghunath Zavar Mangalam Drugs and Organics Limited announced that shareholders approved a special resolution via postal ballot for appointing Mr. Prabhakar Raghunath Zavar (DIN: 11940187), aged 78, as an Independent Director for a five-consecutive-year term. The remote e-voting concluded on 31st Oct'26, recording total valid votes of 5,714,609 across 109 members. The resolution passed with an overwhelming majority, securing 5,711,612 votes (99.9476%) in favor and 2,997 votes (0.0524%) against. Promoter and public institutional categories voted 100% in favor of the proposal.
Original exchange filing (PDF)
More announcements from Mangalam Drugs & Organics Ltd
- Subsequent Intimation of Bank Deafult in Pursuant to Regulation 30 Para A of SEBI (LODR), 2015 路 16 Nov 2026
- Subsequent Intimation of Bank Deafult in Pursuant to Regulation 30 Para A of SEBI (LODR), 2015 路 16 Nov 2026
- Mangalam Drugs And Organics Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 06 Nov 2026
- Disclsoure of Outcome of Board Meeting pursuant to Regulation 30 of SEBI (LODR), 2015 for declaration of Unaudited Financial Results (Standalone and Consolidated) for the quarter and half .... 路 06 Nov 2026
- Intimation under Regulation 36(1)(b) of SEBI (LODR) Regulations, 2015 - Dispatch of Letter for Non- Email Cases 路 04 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters 路 05 Nov 2026
- MANGALAM DRUGS AND ORGANICS LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 05 Nov 2026
- MANGALAM DRUGS AND ORGANICS LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 05 Nov 2026
